Adverse Drug Reactions Machine Learning in Pharmacoepidemiology: How AI is Transforming Post-Market Drug Safety Surveillance in 2026 Joseph NZAYISENGA, B.Pharm, MPH, & MSc | Scopus-Indexed Researcher | Senior Pharmacist & Epidemiologist March 05, 2026 Introduction Pharmacovigilance has historically relied on spontaneous reportin…
